Revenue from Contracts with Customers (Tables)

9 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Three months ended June 30,				Nine months ended June 30,
	2022		2021		2022			2021
Significant Business Line
Life Sciences Products	$	47,369	$	48,625	$	150,861	$	146,490
Sample Repository Solutions		26,000		21,772		78,806		64,496
Genomic Services		59,366		58,690		188,264		165,778
Total	$	132,735	$	129,087	$	417,931	$	376,764

Remaining Performance Obligations

	As of June 30, 2022
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	35,662	$	28,010	$	63,672